BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Rafaqat S, Azam A, Hafeez R, Faseeh H, Tariq M, Asif M, Arshad A, Noshair I. Role of interleukins in the pathogenesis of coronary heart disease: A literature review. World J Cardiol 2025; 17(3): 103947 [PMID: 40161563 DOI: 10.4330/wjc.v17.i3.103947]
URL: https://www.wjgnet.com/1949-8462/full/v17/i3/103947.htm
Number Citing Articles
1
I. F. Shlyk, I. I. Andreeva, M. N. Morgunov, M. V. Kharitonova, D. Yu. Besedina. Cytokine profile of patients with coronary artery calcification without ischemic heart disease.South Russian Journal of Therapeutic Practice 2025; 6(2): 24 doi: 10.21886/2712-8156-2025-6-2-24-31
2
M. V. Khutornaya, A. V. Sinitskaya, O. N. Khryachkova, A. O. Poddubnyak, M. A. Asanov, A. A. Klyueva, M. Yu. Sinitsky, A. V. Ponasenko, O. L. Barbarash. Polymorphisms of genes related to inflammatory response, endothelial dysfunction, lipid metabolism, and oxidative stress in patients with coronary artery diseaseRussian Journal of Cardiology 2025; 30(10): 6366 doi: 10.15829/1560-4071-2025-6366
3
Shicong Xu, Zhihui Zhang, Jing Li, Yiyan Ding, Yuanguo Chen, Yunxia Zhou, Shenglin Hu. Does diabetes status modify the association between the triglyceride-glucose index and major adverse cardiovascular events in patients with coronary heart disease? A systematic review and meta-analysis of longitudinal cohort studiesCardiovascular Diabetology 2025; 24(1) doi: 10.1186/s12933-025-02890-7
4
Stephanie Wissel, Hubert Scharnagl, Marcus E. Kleber, Graciela Delgado, Angela P. Moissl-Blanke, Bernhard Krämer, Winfried März. Reply to the Letter to the Editor: “Anti-inflammatory role of lipoprotein apheresis in the era of small interfering RNA inhibitor of apolipopritein(a)”Clinical Research in Cardiology 2025;  doi: 10.1007/s00392-025-02807-0
5
Yaning Hu, Yuansheng Liu, Yueping Wang, Fengxu Lin, Ronghong Chen, Chuanjun Chen, Tao Qu. Dual-pathway model of IL-6 and HSP22/HSP27 dynamics predicts post-PCI MACE in STEMI patientsBMC Cardiovascular Disorders 2025; 25(1) doi: 10.1186/s12872-025-05304-4
6
M. І. Lutai, O. M. Lomakovsky. Антизапальний ефект аторвастатину в пацієнтів зі стабільною ішемічною хворобою серцяUkrainian Journal of Cardiology 2025; 32(4): 14 doi: 10.31928/2664-4479-2025.4.1421